$IRWD Recent News Ironwood Pharma loss widens as expenses

New Post Public Reply Private Reply Replies (0) Message Board

Nov 13, 2013 at 7:29 PM

$IRWD Recent News

Ironwood Pharma loss widens as expenses soar 8:00 a.m. April 23, 2013 - MarketWatch.com
FDA approves Ironwood's drug for IBS 10:40 a.m. Aug. 30, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 5:06 p.m. March 5, 2012 - Kate Gibson
Ironwood pins hopes on Linaclotid 10:37 a.m. Aug. 16, 2011 - MarketWatch.com
Abolish the FDA; it's insane 9:55 a.m. July 27, 2011 - James Altucher
Ironwood Pharma rallies on positive Phase 3 trial 7:39 a.m. Sept. 14, 2010 - Steve Gelsi

Nothing Should Iritate You About Synergy's Upcoming Catalysts 7:16 a.m. Nov. 6, 2013 - Seeking Alpha
Nothing Should Irritate You About Synergy's Upcoming Catalysts 7:16 a.m. Nov. 6, 2013 - Seeking Alpha
Pipeline Progress at Synergy Pharma - Analyst Blog 5:00 p.m. Nov. 4, 2013 - Zacks.com
10-Q: IRONWOOD PHARMACEUTICALS INC 4:08 p.m. Oct. 28, 2013 - Edgar Online - (EDG = 10Q, 10K)
Weekly 3-Year Low Highlight: EXC, RVBD, IRWD, SHOS 3:50 p.m. Oct. 27, 2013 - GuruFocus.com
UPDATE: Cowen & Company Upgraded Ironwood Pharmaceuticals 2:14 p.m. Oct. 24, 2013 - benzinga.com
First Week Of IRWD December 21st Options Trading 11:52 a.m. Oct. 23, 2013 - TheStreet.com
Ironwood Slips into Loss in Q3 - Analyst Blog 11:00 a.m. Oct. 23, 2013 - Zacks.com
Ironwood Pharmaceuticals Is Now Oversold (IRWD) 4:17 p.m. Oct. 22, 2013 - TheStreet.com
Ironwood Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript 12:20 p.m. Oct. 22, 2013 - Seeking Alpha
Five-Year Lows: Singapore Airlines Limited, Gold Field Ltd., Ironwood Pharmaceuticals Inc. ... 10:04 a.m. Oct. 22, 2013 - GuruFocus.com
Data on Auxilium Pharma's Xiaflex - Analyst Blog 4:35 p.m. Oct. 11, 2013 - Zacks.com
Discovery Labs Surges on Surfaxin News - Analyst Blog 4:15 p.m. Oct. 7, 2013 - Zacks.com
Forest's Patent Infringement Lawsuits - Analyst Blog 1:30 p.m. Oct. 7, 2013 - Zacks.com
Synergy Pharma's Pipeline Holds Promise - Analyst Blog 6:30 p.m. Oct. 4, 2013 - Zacks.com
Ironwood's Linzess Sales Are Ramping Up: Buy The Dip? 9:35 a.m. Sept. 19, 2013 - Seeking Alpha
Ironwood and AstraZeneca Initiate Study - Analyst Blog 4:30 p.m. Sept. 16, 2013 - Zacks.com
Positive News on Roche's Perjeta - Analyst Blog 2:30 p.m. Sept. 13, 2013 - Zacks.com
Data on Novartis' Ultibro Breezhaler - Analyst Blog 5:32 p.m. Sept. 12, 2013 - Zacks.com
Roche and Inovio Tie Up - Analyst Blog 12:00 p.m. Sept. 11, 2013 - Zacks.com

Upcoming Earnings Schedules, Conferences and Quarterly Financial Results - Research Report on Supernus, Ironwood, Neurocrine Biosciences, PhotoMedex, and Kythera 8:00 a.m. Nov. 11, 2013 - PR Newswire
Ironwood Pharmaceuticals to Present at Credit Suisse 2013 Healthcare Conference 4:00 p.m. Nov. 6, 2013 - BusinessWire
Partnership, Quarterly Reports, Acquisition, and Publication - Research Report on Alere, Ironwood, Magellan Health Services, Foundation Medicine, and InterMune 8:00 a.m. Oct. 28, 2013 - PR Newswire
Ironwood Pharmaceuticals Provides Third Quarter 2013 Investor Update 6:10 a.m. Oct. 22, 2013 - BusinessWire
Ironwood Pharmaceuticals to Host Third Quarter 2013 Investor Update Call 3:00 p.m. Oct. 8, 2013 - BusinessWire
Dividend Increases, Research Nominations, New Treatment Options, and Clinical Trials - Research Report on Covidien, Ironwood, ICON, Novadaq, and Antares 7:00 a.m. Oct. 2, 2013 - PR Newswire
Ironwood and AstraZeneca Initiate Linaclotide Phase III Trial in China for Adults with IBS-C 7:00 a.m. Sept. 10, 2013 - BusinessWire
Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference 3:00 p.m. Sept. 3, 2013 - BusinessWire
Positive Clinical Trial Results, Regulatory Wins, and New Appointments - Research Report on Incyte, Edwards, ACADIA Pharmaceuticals, Alnylam, and Ironwood 7:00 a.m. Aug. 26, 2013 - PR Newswire
Ironwood Pharmaceuticals Appoints Dr. Michael Hall as Senior Vice President of Clinical Development 7:00 a.m. Aug. 21, 2013 - BusinessWire
Earnings Releases, Investment Plans, Commencement of Clinical Trials, and FDA Applications Brighten Outlook - Research Report on Bard, Centene, Exact Sciences, Ironwood, and Merrimack 7:00 a.m. July 26, 2013 - PR Newswire
RDInvesting Provides Investors with Free In-Depth Equity Reports on DHI, EZCH, IRWD and NUE 7:31 a.m. July 25, 2013 - ACCESSWIRE
Ironwood Pharmaceuticals Provides Second Quarter 2013 Investor Update 6:05 a.m. July 23, 2013 - BusinessWire
Ironwood Pharmaceuticals to Host Second Quarter 2013 Investor Update Call 3:00 p.m. July 9, 2013 - BusinessWire
Innovative Technologies that Yield Improved Treatments - Research Report on Mettler-Toledo, Ironwood, Covance, Teleflex and WuXi 7:00 a.m. June 26, 2013 - PR Newswire
Ironwood Pharmaceuticals Announces Partial Exercise of Underwriters' Option in Public Offering of Common Stock 3:00 p.m. June 4, 2013 - BusinessWire
Further Expansions and Positive Study Results Drive Healthcare Companies - Research Report on Agilent, Thermo Fisher, BG Medicine, Quest Diagnostics, and Ironwood Pharmaceuticals 7:00 a.m. May 31, 2013 - PR Newswire
Ironwood Pharmaceuticals Prices Public Offering of Common Stock 5:30 p.m. May 21, 2013 - BusinessWire
Ironwood Pharmaceuticals Announces Proposed Public Offering of Common Stock 3:05 p.m. May 20, 2013 - BusinessWire
Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week(R) 2013 7:00 a.m. May 14, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innodata Faces Investigation After Major Stock Drop

Rough Waters for Innodata, Stock Takes a Hit The market can be a brutal place when news hits hard, and that's precisely the situation Innodata Inc. (NASDAQ: INOD) found itself in on October 27, 2026. After a promising rally, the company's shares plummeted by over 20% when news broke of a significant workforce reduction overseas. Unpacking the Numbers Behind the Dive The...

FIU Cuba Poll: Cuban American Vote Leans GOP

Here we got the latest scoop from the 2026 FIU Cuba Poll, and boy, it's a wild ride. Picture this: 76% of Cuban Americans in South Florida aren't fans of Trump’s escalated deportations of Cubans sans criminal records, yet a solid 68% are sticking to their GOP guns come election season. Now, ain't that a head-scratcher? Cuban Americans and the GOP: A Complex Relationship...

Personalis Merger Faces Investigation: $16.25 Offers Scrutinized

Market Storm or Light Drizzle? When the sharks smell blood or the legal eagles start circling, you know something stinks. BFA Law is sniffing around, and it isn’t just for sport. They’re putting their magnifying glass on this curious $16.25 per share transaction where Tempus AI plans to gobble up Personalis lock, stock, and barrel. For investors holding NASDAQ:PSNL,...

Unlocking Airbnb Success: Expert Tips on Design Features

Design's Role in Capturing Airbnb Guests Alright, folks, let's dissect what really gets those Airbnb bookings. Wendy Anguiano, no stranger to sprucing up coastal rentals, dishes the dirt on design elements that scream 'book me' on first click. She's hailed from Design & Dwell Homes, operating right from the heart of Santa Rosa Beach, Florida. It's a fierce market out...

CMS Energy's Q3 Marks Change: Restructuring Boost

A Tale of Two Earnings Few things get my blood pumping like a new quarter's earnings dance, and CMS Energy (NYSE:CMS) is stealing the show right now with its two-faced Q3 results. Digging deep into the numbers, we see this Michigan-based energy player reporting a gauntlet of figures that have investors raising their eyebrows. On one hand, reported GAAP earnings dropped to...

Bracco's $230M U.S. Expansion: A Strategic Leap

Bracco's Bold Move into U.S. Manufacturing In the bustling world of diagnostic imaging, Bracco's latest announcement is like a welcome jolt. They're shelling out $230 million for a new manufacturing facility in Sanford, North Carolina. If you've been around the block in this sector, this move screams ambition—Bracco's playing the long game here. Strategic Location: A...

Infosys Transforms Syngenta's Tech Core to Boost Agility

Unpacking the Syngenta-Infosys Transformation Forget your run-of-the-mill tech upgrade; Infosys has just spearheaded a massive transformation for Syngenta, delivering a new global SAP S/4HANA setup that’s set to turbocharge their Crop Protection business. We’re talking about more than just another software upgrade here—this is a sweeping overhaul affecting 10,000...

EDGE Sound Research Boosted by $2M from Stormbreaker

EDGE Sound Research: Shaping Future with Sound Folks are starting to whisper more about EDGE Sound Research these days, and for good reason. This little outfit based out of Riverside, California just took in another $2 million from Stormbreaker Ventures, lifting its total funding to $9 million. But what are they doing with all that cash? They're building the perception...

BAC Shareholders Face Class Action: Fraud Allegations

Legal Storm Brewing Over Bank of America If you thought the banking sector was a safe harbor, folks, take a gander at the latest happening with the Bank of America Corporation (NYSE: BAC). The old titans aren't immune to legal turmoil, as evidenced by the ruckus over a $1.2 billion fine slapped on the bank for violations involving anti-money laundering laws. Now, a...

Nevada King's Gold Drilling Could Yield Big Returns

Unlocking Gold's Potential: A First Look Another day, another drill result, and this time it's Nevada King Gold Corp. (TSXV: NKG) (OTCQX: NKGFF) dropping the headlines. They've been playing in the dirt at their Atlanta Gold Mine Project in Nevada, unveiling numbers that might shake some of you out of your chairs. Peeking Into East Ridge and Silver Park Let's talk turkey,...